CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
GORE® TAG® Thoracic Branch Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02264977
NCT02264977N/ACompleted

Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (Branched TAG® Device) in the Treatment of Aortic Arch Aneurysms

W.L.Gore & Associates·interventional·Posted Oct 15, 2014·Updated Sep 14, 2022

In Brief

A clinical study evaluating GORE® TAG® Thoracic Branch Endoprosthesis for Aneurysm of Aortic Arch. Completed, enrolled 9 participants across 6 sites.

Detailed Summary

The purpose of this study is to assess the early feasibility of the use of the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms involving the aortic arch

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 15, 2014
Enrollment StartApr 1, 2015
Primary CompletionJul 1, 2016
Study CompletionMar 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.7 years ago

Interventions

GORE® TAG® Thoracic Branch Endoprosthesisdevice